Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments

Published Date: 16 Sep 2024

Incidence almost identical to that with standard cancer treatment in randomized trials

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

2.

Cancer care crowdfunding increasingly common, but rarely successful

3.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

4.

High Rate of Deep Remission for Relapsed/Refractory CLL Using Triple Regimen.

5.

No Survival Gain With Preoperative CRT Plus Perioperative Chemo for Gastric Cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot